Xolair 300 MG/2 ML autoinject 2ML

Ended Awarded

Contract number
SPE2DR26FCLLQ
Awardee
Awarding agency
Obligated
$1,747

Award facts

Contract value 100% obligated
$1,747.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $1,747.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 14, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Xolair 300 mg/2 ml autoinjector.

PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The order has a firm fixed price and an ultimate completion date of August 4, 2026.

Quick answers

Who was awarded contract SPE2DR26FCLLQ?

SPE2DR26FCLLQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2026.

How much is contract SPE2DR26FCLLQ worth?

The government has obligated $1,747 on SPE2DR26FCLLQ.

Is contract SPE2DR26FCLLQ an order under another contract?

Yes. SPE2DR26FCLLQ is a delivery order under SPE2DR25D9130, an indefinite delivery contract.

Was contract SPE2DR26FCLLQ competed?

The extent of competition for SPE2DR26FCLLQ was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login